Raquel Aloyz
- Developmental Neuroscience top 0.5%
- Cellular and Molecular Neuroscience top 0.5%
- Neuropeptides and Animal Physiology 10
- Nerve injury and regeneration 9
- Biological Psychiatry top 2%
- Behavioral Neuroscience top 2%
- Molecular Biology top 5%
- DNA Repair Mechanisms 21
- Cancer therapeutics and mechanisms 7
-
- Chronic Lymphocytic Leukemia Research 21
-
- Cancer-related Molecular Pathways 9
-
- Chronic Myeloid Leukemia Treatments 8
-
- Acute Lymphoblastic Leukemia research 7
Raquel Aloyz
71 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Developmental Neuroscience 892
- Cellular and Molecular Neuroscience 1.9k
- Biological Psychiatry 158
- Behavioral Neuroscience 216
- Molecular Biology 2.1k
Countries citing papers authored by Raquel Aloyz
This map shows the geographic impact of Raquel Aloyz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel Aloyz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel Aloyz more than expected).
Fields of papers citing papers by Raquel Aloyz
This network shows the impact of papers produced by Raquel Aloyz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel Aloyz. The network helps show where Raquel Aloyz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Raquel Aloyz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2020 | 6 | |
| 4 | 2019 | 9 | |
| 5 | 2018 | 27 | |
| 6 | 2018 | 24 | |
| 7 | 2018 | 36 | |
| 8 | 2015 | 18 | |
| 9 | 2012 | 49 | |
| 10 | 2011 | 18 | |
| 11 | 2011 | 74 | |
| 12 | 2011 | 13 | |
| 13 | 2011 | 4 | |
| 14 | 2009 | 13 | |
| 15 | 2008 | 49 | |
| 16 | Dasatinib sensitizes chronic lymphocytic leukemia lymphocytes to chemotherapeutic agents | 2007 | 1 |
| 17 | 2007 | 12 | |
| 18 | 2005 | 57 | |
| 19 | 2002 | 43 | |
| 20 | 1992 | 2 |
About Raquel Aloyz
Raquel Aloyz is a scholar working on Genetics, Developmental Neuroscience and Cellular and Molecular Neuroscience, having authored 74 papers that have together received 4.1k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (21 papers), Chronic Lymphocytic Leukemia Research (21 papers), Neuropeptides and Animal Physiology (10 papers), Cancer-related Molecular Pathways (9 papers), Nerve injury and regeneration (9 papers), Chronic Myeloid Leukemia Treatments (8 papers), Cancer therapeutics and mechanisms (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). The work is most often cited by research in Developmental Neuroscience (892 citations), Cellular and Molecular Neuroscience (1.9k citations) and Biological Psychiatry (158 citations). Raquel Aloyz has collaborated with scholars based in Canada, United States and Argentina. Frequent co-authors include Freda D. Miller, Shernaz X. Bamji, Lawrence Panasci, Carrie G. Causing, J. Paul Fawcett, Marta Majdan, Christine D. Pozniak, Lilian Amrein, Jean G. Toma and Daniel J. Belliveau.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.